There are “myths” that surround the use of GLP-1 receptor agonists among patients, and it is a health care provider’s role to help their patients understand the benefits and adverse effects of these...
The incidence rate for many types of eosinophilic disorders is unknown, often due to gaps in the literature. How often do you see eosinophilic disorders, such as simple pulmonary eosinophilia in your...
Which treatment-related manifestation has led you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)? Let us know by taking our poll.
The girl had had rhinorrhea, frontal headache, and watery eyes for 1 week prior to the vomiting, for which she had been treated with loratadine, 5 mg/d.
